Yes, you can have features of both type 1 and type 2 diabetes at the same time. The condition is known as double diabetes (sometimes called hybrid diabetes), and it occurs when someone with type 1 diabetes also develops the insulin resistance that defines type 2. It’s not an official diagnostic category yet, but it’s increasingly recognized by endocrinologists as a real and distinct clinical pattern.
What Double Diabetes Actually Means
Type 1 and type 2 diabetes have different root causes. In type 1, the immune system destroys the cells in the pancreas that produce insulin, so the body can’t make its own. In type 2, the body still produces insulin but stops responding to it efficiently, a problem called insulin resistance. Double diabetes is what happens when both problems coexist: a person with type 1 diabetes whose body also becomes resistant to the insulin they inject.
The result is a frustrating cycle. You need insulin to survive because your pancreas doesn’t produce it, but your body doesn’t use the injected insulin effectively. That means you need higher and higher doses to keep blood sugar in range, which can lead to weight gain, which worsens the resistance further.
How It Develops
The process typically starts with type 1 diabetes. Over time, several biological mechanisms can push someone toward insulin resistance. One of the most straightforward is weight gain. Insulin is a growth-promoting hormone, and people who take it daily sometimes gain excess fat tissue. That extra fat releases free fatty acids and hormones that directly oppose insulin’s action, making each dose less effective.
There’s also a feedback loop involving the insulin itself. Chronically elevated insulin levels, especially from doses that are slightly higher than needed, cause the body to pull insulin receptors off the surface of cells. Fewer receptors means less response, which means you need even more insulin. The cycle compounds itself.
At the cellular level, fat buildup inside muscle cells disrupts the signaling chain that normally lets insulin shuttle sugar from the bloodstream into tissue. Specific fat byproducts interfere with the proteins that trigger glucose transporters to move to the cell surface. On top of that, the oxidative stress caused by high blood sugar can damage those same signaling pathways independently, creating multiple routes to resistance even without significant weight gain.
Who Is Most at Risk
Family history is one of the strongest predictors. If you have type 1 diabetes and close relatives with type 2, your risk of developing double diabetes rises substantially. Several sets of diagnostic criteria proposed over the past three decades have included family history of type 2 as a key marker, with one framework specifying type 2 diabetes in at least two relatives.
Body weight matters too. A BMI above the 85th percentile for age has been flagged as a clinical threshold that should prompt closer evaluation for insulin resistance in people with type 1. But weight alone doesn’t tell the whole story. Researchers have developed an insulin resistance scoring system that factors in waist-to-hip ratio, blood pressure, HDL cholesterol, triglyceride levels, and family history. A person can check several of those boxes without being particularly heavy.
The practical signs tend to be things you’d notice in daily management: needing unusually high insulin doses to maintain target blood sugar, gaining weight on insulin therapy, developing high blood pressure, or seeing HDL cholesterol drop.
Why It Matters for Your Health
Double diabetes combines the cardiovascular risks of type 2 with the blood sugar volatility of type 1. Insulin resistance is a hallmark of metabolic syndrome, a cluster of conditions (excess abdominal fat, high blood pressure, abnormal cholesterol, elevated blood sugar) that collectively raise the risk of heart disease and stroke. When someone already living with type 1 adds metabolic syndrome to the picture, their risk profile shifts significantly. Research has confirmed that a family history of type 2 diabetes mediates cardiovascular risk in people with type 1, highlighting how intertwined these pathways are.
The complications that affect small blood vessels, like damage to the eyes, kidneys, and nerves, also worsen when insulin resistance is present. Poorly controlled blood sugar accelerates all of these, and resistance makes control harder to achieve.
How Doctors Identify It
There is no single test that stamps “double diabetes” on a chart. Instead, clinicians look for patterns. The most validated tool for estimating insulin resistance in people with type 1 is called the estimated glucose disposal rate, or eGDR. It uses three routine measurements: your HbA1c (a three-month blood sugar average), your waist circumference, and whether you have high blood pressure. A score below 8 on this scale suggests clinically meaningful insulin resistance.
The gold standard for measuring insulin resistance is a specialized lab procedure called a clamp test, but it’s expensive, invasive, and time-consuming, so it’s rarely used outside of research. The eGDR correlates well with clamp results and can be calculated from numbers your doctor already collects at a routine visit.
Managing Both Problems at Once
Insulin remains non-negotiable. If you have type 1 diabetes, you need exogenous insulin to survive, and that doesn’t change with a double diabetes diagnosis. What changes is the addition of strategies aimed specifically at reducing resistance.
Metformin, a cornerstone of type 2 treatment, is increasingly prescribed off-label for people with type 1 who show signs of insulin resistance. Because metformin works independently of the pancreas, improving how the liver and muscles respond to insulin rather than stimulating insulin production, it can reduce the total daily insulin dose a person needs.
Newer medications originally developed for type 2, particularly GLP-1 receptor agonists like semaglutide and liraglutide, are also being used off-label in this population. These drugs promote weight loss and appear to improve insulin sensitivity as fat tissue decreases. The dual-action drug tirzepatide, which targets two hormone pathways simultaneously, is being used as well. A practical barrier is that insurance companies sometimes deny coverage for these medications when prescribed for type 1, since they’re only FDA-approved for type 2.
Exercise and Diet
Regular aerobic exercise directly increases insulin sensitivity in people with type 1 diabetes. It also reduces oxidative stress and improves blood vessel function, both of which contribute to better insulin signaling. Meta-analyses show that consistent aerobic training programs improve both short-term and long-term blood sugar control. Adding short bursts of high-intensity effort to aerobic sessions may also reduce the risk of delayed low blood sugar episodes that sometimes follow exercise in people on insulin.
On the dietary side, meals with a high glycemic index worsen postprandial blood sugar spikes, raise HbA1c, and lower HDL cholesterol in people with type 1. Replacing some carbohydrate intake with sources of monounsaturated fat (olive oil, avocados, nuts) lowers the glycemic impact of meals without increasing heart disease risk. The goal isn’t a restrictive diet but a shift toward foods that produce a gentler blood sugar curve, making your existing insulin doses more effective.
How Common Is Double Diabetes
Prevalence estimates vary widely because there’s no universally agreed-upon definition. Different research groups have used different criteria since the concept was first described in 1991, making it hard to pin down a single number. What’s clear is that rates of overweight and obesity have risen among people with type 1 diabetes just as they have in the general population, and insulin resistance is common in this group. As the overlap grows, double diabetes is likely becoming more frequent even if the formal recognition hasn’t caught up.
The lack of a standardized diagnosis also means many people living with this pattern don’t have a name for it. If you have type 1 diabetes and find yourself needing steadily increasing insulin doses, gaining weight despite careful management, or developing high blood pressure and abnormal cholesterol, the explanation may be that you’re dealing with both sides of the diabetes spectrum simultaneously.